DeepCell Industries Competitors

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

As a company founded and led by research scientists, we’re working to help unlock the secrets of life. To empower the global scientific community, accelerate biological understanding, and enable personalized medicine. And we believe in the power and promise of science to solve the challenges we face as a global community. Because we’re scientists, we understand your needs as a researcher. We know what it takes to achieve meaningful results— the patience, rigor, sacrifice, and dedication. And we know you have to be able to rely on the tools you use in your investigations, whether in an academic setting or an industry one. That’s why we’re so fanatical about the quality of our antibodies and other products. And why we’re dedicated to providing our customers with the best possible service and support. Engaging in solutions-focused consultation and support is a foundational part of who we are and what we do. Every day, we work to develop innovative, proven solutions that can help you find the answers you’re looking for—answers that can lead to better understanding, diagnosis, and treatment of disease.